# Phase 2 Editor Report (Revision 2 pass) — telehealth-hub-refresh

**Input:** `draft-v5-revision2.md` (orchestrator applied all 10 Revision 2 comments + 2 previously-open resolutions on top of the approved `draft-v4-publisher-final.md`)
**Output:** `draft-v6-editor-final.md`
**Mode:** Quality assurance, not a rewrite. `draft-v5` already reflects a precise, approved editorial pass. Two targeted flow fixes made (both inside the comment-6 vendor rewrites); the draft was otherwise clean. Status set to `edited`; no other frontmatter touched (publisher pass finalizes frontmatter).

## Pass/fail summary

| # | Check | Result |
|---|-------|--------|
| 1 | Terminology / abbreviation (M1), reading order | PASS — every acronym expanded once at first standalone use, acronym-only thereafter; removed acronyms (TLS/S3/SSE-S3) fully absent |
| 2 | Terminology guardrails (Asseyla: audience/objective/reader/by hand; we/our/you contexts) | PASS — "audience" removed per comment fix; no banned terms; we/our/you all in permitted contexts |
| 3 | Banned-word / AI-signature (§6) | PASS — grep clean; no body em-dash, no "not just X it's Y", no hype triples |
| 4 | Claims accuracy vs approved_claims + banned_claims | PASS — all numbers trace to an FX-claim; byte-identical across body/FAQ; removed "essential/beneficial fat" correctly absent (intentional cut, not a missing claim) |
| 5 | M2 stacked negation (newly rewritten sentences) | PASS — FAQ answers, §5 workflow, Privacy paragraphs all single-negation-plus-positive |
| 6 | Comment-9 trims did not leave a section incomplete/ambiguous | PASS — §2/§5/§7 and FAQ Q2 all read complete; boundary carried elsewhere in each case |
| 7 | Link verification (3 new external + 1 changed internal, used ×2) | PASS — all resolve to approved/verified targets; anchor text descriptive, no bare URLs / no "click here" |
| 8 | Voice / expert polish | PASS after 2 fixes — repetitive-phrasing echoes in the comment-6 vendor sentences smoothed |

No `❌`. Two `⚠️` carried-forward open items (unchanged from prior passes) plus one new low-priority flag, all non-blocking, listed at the end.

---

## Check 1 — M1 abbreviations (first standalone use, verified in reading order)

| Acronym | First use (expanded) | Later uses acronym-only? |
|---------|----------------------|--------------------------|
| RPM | §2 "Remote patient monitoring (RPM)" | §3 uses the full phrase as a section-label header (not a re-expansion of the parenthetical) — compliant |
| ECG | §3 "portable electrocardiogram (ECG) recorder" | not reused |
| BMI | §5 "Body Mass Index (BMI)" | FAQ Q4 "BMI" — acronym only |
| BMR | §5 "basal metabolic rate (BMR)" | FAQ Q4 "BMR" — acronym only |
| API | §5 "application programming interface (API)" | §9 + FAQ Q2 "API" — acronym only |
| DEXA | §5 "dual-energy X-ray absorptiometry (DEXA)" | §8 + FAQ Q3 "DEXA" — acronym only (the FAQ Q3 re-spell was trimmed in Revision 2; re-verified gone) |
| HIPAA | §7 "Health Insurance Portability and Accountability Act (HIPAA)" | FAQ Q5 "HIPAA" — acronym only |
| BAA | §7 "Business Associate Agreement (BAA)" | §9 + FAQ Q5 "BAA" — acronym only |
| GDPR | §7 "General Data Protection Regulation (GDPR)" | FAQ Q5 "GDPR" — acronym only |

- TLS / Amazon S3 / SSE-S3 removed in Revision 2 (comment 7) — grep-confirmed absent everywhere, so no orphaned unexpanded acronym.
- "AI" left unexpanded (ubiquitous; per guardrail exception, same as prior passes).
- DEXA first-use is genuinely in §5 (no earlier body mention); expansion sits at first use. Correct.

## Check 2 — Terminology guardrails (`content-strategy/terminology-guardrails.md`)

The file was located this pass (it was missing/unlocatable in the v3/v4 reports). Verified against its actual rules:

- **"audience"** (rule: NEVER) — the §1 instance flagged in `phase3-publisher-report.md` is gone. Revision 2 reformulated it to "That question matters most to care teams…". Grep for "audience" in the body: no matches. Resolved.
- **objective / reader / by hand / this article / this guide / the following / below** — grep clean, none present in body.
- **we / our** (apply only where ownership matters) — 5 instances, all ownership: "our body-scanning accuracy framework," "our accuracy framework" (×2), "our [body-scanning accuracy framework]" Related bullet, "our team" (CTA). All are the company owning a resource or the demo offer. Compliant.
- **you / your** (allowed in conversion / practical-guidance sections only) — confined to the §9 evaluation checklist ("which one you are buying," "your interface") and the closing conversion CTA ("could fit your remote-care workflow"). Both are permitted contexts. No "you" in the neutral educational sections. Compliant.

## Check 3 — Banned-word / AI-signature scan

Grep (case-insensitive) for `leverage|utilize|utilizing|harness|robust|seamless|comprehensive|delve|navigate|tapestry|realm|unlock|unleash|revolutionary|cutting-edge|game-chang|disrupt|Furthermore|Moreover|Additionally` → **no matches**.

Grep for `—|–` → one match only, in the **frontmatter** `action_type` provenance note (`"…Vadim override 2026-07-27 — ran full pipeline…"`). This is an internal metadata field, not reader-facing body rhetoric, and it is not the "X — is not just Y" construction the §6 rule targets. Left as-is (frontmatter is finalized by the publisher pass); flagging for the publisher to normalize the dash if desired. No em-dash anywhere in the body. The only "→" glyph is inside the "Two Photos → Structured Body Data" link anchor (intended, unchanged).

No "not just X, it's Y". Enumerations checked for hype triples: the lists present ("intake, processing, structured-data delivery, provider review, documentation, and follow-up"; "pose, clothing, framing, lighting, and camera placement"; "Clinical, triage, and eligibility decisions") are genuine multi-item enumerations or consistent boundary language, not the "fast, reliable, scalable" rhythmic-triple pattern.

## Check 4 — Claims accuracy

Every number traces to an approved FX-claim and is byte-identical across body and FAQ (grep-verified):

| Claim | Value in draft | FX-id | Body / FAQ match |
|-------|----------------|-------|------------------|
| Measurements | "more than 80 body measurements" | FX-006 | §5 = FAQ Q4, identical |
| Time to results | "under 45 seconds" | FX-005 | §5 = FAQ Q4, identical |
| Repeatability | "…typical scan-to-scan differences of less than 1 cm." | FX-003 | §5 = FAQ Q7, identical |
| Yazen figure | "recorded about 34,000 scans in 2025" (internal, company unnamed) | FX-010 | §5 only (removed from FAQ per comment 5) |
| Body composition | predicted weight, BMI, BMR, body-fat %, lean mass, fat mass | FX-007 | §5 = FAQ Q4, consistent |
| HIPAA / BAA / GDPR | support language | FX-012 / FX-013 | §7 = FAQ Q5, consistent |
| Encryption | "encrypted in transit and at rest" | FX-014 | §7 (simplified per comment 7) |
| Retention | "deleted after processing by default" | FX-015 | §7 |
| Identifiers | "no names or direct personal identifiers" | FX-016 | §7 |

- **"Essential and beneficial fat"** — confirmed absent (grep clean). This is the intentional comment-3 / live-page-verified cut, NOT a missing claim. Not flagged as an error, per the task note. (The `proof-points.md` vs. live-page discrepancy remains an open item for Product — see below.)
- Banned content confirmed absent: no GLP-1 eligibility language, no UK Meds / pharmacy-BMI-compliance claim, no bare 96–97% accuracy figure (correctly routed to the accuracy framework), no SOC 2 / FDA assertion, no competitor names, no diagnosis/decisioning/replace-clinician assertions.
- `claims_used` unchanged and complete: FX-003, FX-005, FX-006, FX-007, FX-010, FX-012, FX-013, FX-014, FX-015, FX-016.

## Check 5 — M2 stacked negation (Revision-2-rewritten sentences)

Re-read every sentence changed this pass for accidental double/interrupted negation. None introduced.

- §2 close: "It supplements manually entered body data with a more standardized capture record for provider review." — positive.
- Remote-body-data-gap open + FAQ Q8: "Self-reported measurements can vary with the patient's equipment, technique, recall, and reporting format…" — positive, one clean clause.
- §5 workflow close: "A provider reviews the data, and the results can then be documented according to the program's workflow." — positive.
- Privacy close: "The layer supports compliant workflows, and the program itself owns the compliance outcome." — positive.
- FAQ Q5 (HIPAA): "Organizations remain responsible for assessing and managing compliance across their complete implementation…" — positive.
- FAQ Q3 (DEXA) and Q6 (clinical decisions): each carries exactly one clear boundary negative followed by a positive scope statement ("Its strongest role is…", "…decisions stay with the care team"). Compliant with the "one clear negative per sentence" rule.
- §1 scope note and closing disclaimer retain the phase-2 split (one negative per sentence). Unchanged, still compliant.

## Check 6 — Comment-9 trims: completeness / flow

Read each shortened section for whether the cut left it incomplete or ambiguous. All still read complete because the boundary is carried elsewhere in each case:

- **§5 workflow paragraph** — the cut trailing "…does not decide, triage, or flag anything on its own" is redundant with §8's four explicit boundaries and the §1 scope note. Paragraph now ends cleanly on "documented according to the program's workflow." No loss of meaning.
- **Privacy close** — the restated medical-device/compliance clause was cut, but §7's opening still states "Compliance is framed on data-privacy grounds rather than medical-device grounds" and "the program itself owns the compliance outcome." Boundary intact; the section now closes on the legal-center pointer without a redundant aside.
- **FAQ Q2** — the trailing "The scan supports the workflow rather than replacing any human step" was cut; Q2 still answers the "how does it fit" question fully (capture step + provider review). The replace-a-human-step point lives in Q3/Q6 and §8. No ambiguity.
- **§2 close** — reads coherently end-to-end after the self-report softening. Not over-trimmed.

Verdict: no section reads truncated; the de-duplication improved density without removing substance.

## Check 7 — Link verification

| Location | URL | Status |
|----------|-----|--------|
| §3 KardiaMobile | https://alivecor.com/products | New this pass; verified live in changelog §6; anchor "KardiaMobile device from AliveCor" reads naturally |
| §3 Ada Health | https://www.ada.com | New; verified live; anchor "Ada Health" |
| §3 Augmedix | https://www.augmedix.com/product-overview | New; verified live; anchor "Augmedix" |
| §5 accuracy anchor | https://3dlook.ai/content-hub/mobile-body-scanning-accuracy/ | Approved (unchanged) |
| §5 two-photos anchor | https://3dlook.ai/content-hub/3dlook-turns-two-photos-structured-body-data/ | Approved (unchanged) |
| §7 legal center | https://3dlook.ai/legal/ | Approved (unchanged) |
| Related — technology | …/3dlook-turns-two-photos-structured-body-data/ | Approved |
| Related — evidence | …/mobile-body-scanning-accuracy/ | Approved |
| Related — workflow | …/online-pharmacy-bmi-verification-a-2026-compliance-guide/ | Approved (sideways-only) |
| Related — product fit | https://3dlook.ai/structured-body-data-for-telehealth-digital-health-programs/ | Changed this pass (old product page → current canonical); anchor "Telehealth & Digital Health" |
| Closing CTA | https://3dlook.ai/structured-body-data-for-telehealth-digital-health-programs/ | Same new URL; anchor "FitXpress for Telehealth & Digital Health" |

- The old down-link `…/fitxpress/for-telehealth-and-weight-loss/` is grep-confirmed absent; both instances now point to the current canonical product page.
- All anchor text is descriptive; no bare URLs, no "click here" — compliant with the terminology-guardrails "Internal & Third-Party Linking" rule.
- Excluded links still absent: no GLP-1 hub/compliance, no visual-progress-GLP-1, no accuracy-drives-ROI, no "Admin Panel launch" article link.

## Check 8 — Voice / expert polish (2 fixes)

Both fixes are inside the comment-6 vendor rewrites, where the generalization introduced a within-passage word echo (repetitive-phrasing rule).

**Fix 1 — §3 Remote patient monitoring bullet.**
- Before: "…lets patients record heart activity at home for provider review. Depending on the product and configuration, accompanying software may analyze the recording and surface findings **for provider review**."
- After: "…and surface findings **for the reviewing clinician**."
- Rationale: "for provider review" appeared twice in two consecutive sentences. Reworded the second to remove the echo. No claim or boundary change.

**Fix 2 — §3 Virtual triage bullet.**
- Before: "These tools gather symptom detail **before a consultation**, which can give the clinician a structured symptom history to review **before or during the consultation**."
- After: "These tools gather symptom detail **ahead of the visit** and can give the clinician a structured symptom history to review before or during the consultation."
- Rationale: "consultation" and "before" each repeated inside one sentence. Merged and reworded the front half; kept the comment-6-approved "structured symptom history to review before or during the consultation" phrasing intact. No claim change.

Otherwise the draft reads as genuine B2B operational writing: the reframe move is present ("not 'how accurate is it?' but 'accurate enough for which decision?'"), declarative rhythm, concrete-over-abstract, limits stated alongside capability, buyer framing. No further edits needed — the rest of the draft is clean, so no rewrite-for-its-own-sake was done.

---

## Open items for Vadim / Asselya (flag, don't decide — guardrail #11)

1. **`proof-points.md` vs. live product page — body-composition outputs.** `proof-points.md` (FX-007) still lists "essential/beneficial fat"; the live Telehealth & Digital Health page and this article do not. The article correctly follows the live page (comment 3). Recommend Product reconcile `proof-points.md` so future articles don't reintroduce it. (Carried from the Revision 2 changelog; not an article defect.)
2. **Ada Health link is the homepage** (`https://www.ada.com`), not a symptom-assessment-specific deep page — no more specific official URL surfaced during verification. Acceptable as official product documentation; flagging in case a preferred deep link exists. (Carried from changelog.)
3. **"FitXpress Admin Panel" product-feature mention** (§5 body + FAQ Q2) — unchanged this pass; Revision 2 didn't touch it. Same status as `phase2-editor-report.md` / `phase3-publisher-report.md`: it's the product-feature delivery surface, not the excluded "Admin Panel launch" article (no link to that article exists). Confirm acceptable, or ask for softening to "a vendor console."
4. **Audience-segment filtering** (telehealth vs. GLP-1 boundary in `audience.md`) — unchanged this pass; no new information. Carried forward for Vadim/Asselya confirmation that Segment 1 filtered off GLP-1 is sufficient.
5. **New, low priority — em-dash in frontmatter `action_type`** provenance note (line 4). Not body rhetoric and not the §6-targeted construction, so not a body-copy failure, but the publisher may want to normalize it (e.g., to a comma or parenthetical) when finalizing frontmatter, since the piece is otherwise dash-free.

None of the above is a positioning / compliance / cannibalization failure. Total non-passing/flagged: 0 fails, 5 flags (4 carried, 1 new low-priority). Well under the "≥2 ❌ → STOP" threshold.

## Verdict

**PROCEED to publisher pass.** All eight editor checks pass. Two targeted repetitive-phrasing fixes applied in §3; no other prose changed. `draft-v6-editor-final.md` is ready for the publisher pass (frontmatter finalization + final checklist).
